| 1 |
Hedayat M, Ahmadi M, Shoaran M, Rezaie J. Therapeutic application of mesenchymal stem cells derived exosomes in neurodegenerative diseases: A focus on non-coding RNAs cargo, drug delivery potential, perspective. Life Sci 2023;320:121566. [PMID: 36907326 DOI: 10.1016/j.lfs.2023.121566] [Reference Citation Analysis]
|
| 2 |
Zhang C, Talifu Z, Xu X, Liu W, Ke H, Pan Y, Li Y, Bai F, Jing Y, Li Z, Li Z, Yang D, Gao F, Du L, Li J, Yu Y. MicroRNAs in spinal cord injury: A narrative review. Front Mol Neurosci 2023;16:1099256. [PMID: 36818651 DOI: 10.3389/fnmol.2023.1099256] [Reference Citation Analysis]
|
| 3 |
Li RY, Hu Q, Shi X, Luo ZY, Shao DH. Crosstalk between exosomes and autophagy in spinal cord injury: fresh positive target for therapeutic application. Cell Tissue Res 2023;391:1-17. [PMID: 36380098 DOI: 10.1007/s00441-022-03699-6] [Reference Citation Analysis]
|
| 4 |
Xia Y, Zhu J, Yang R, Wang H, Li Y, Fu C. Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges. Front Immunol 2023;14:1141601. [PMID: 36911700 DOI: 10.3389/fimmu.2023.1141601] [Reference Citation Analysis]
|
| 5 |
Zhang Y, Wu W, Pan X, Wang Y, Wu C, Lu L, Yu X, Li Y. Extracellular vesicles as novel therapeutic targets and diagnosis markers. Extracellular Vesicle 2022;1:100017. [DOI: 10.1016/j.vesic.2022.100017] [Reference Citation Analysis]
|
| 6 |
Abdolmohammadi K, Mahmoudi T, Alimohammadi M, Tahmasebi S, Zavvar M, Hashemi SM. Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation. Life Sci 2022;312:121206. [PMID: 36403645 DOI: 10.1016/j.lfs.2022.121206] [Reference Citation Analysis]
|
| 7 |
Yang Z, Rao J, Liang Z, Xu X, Lin F, Lin Y, Wang C, Chen C. Efficacy of miRNA-modified mesenchymal stem cell extracellular vesicles in spinal cord injury: A systematic review of the literature and network meta-analysis. Front Neurosci 2022;16:989295. [DOI: 10.3389/fnins.2022.989295] [Reference Citation Analysis]
|
| 8 |
Zhao Y, Chen Y, Wang Z, Xu C, Qiao S, Liu T, Qi K, Tong D, Li C. Bone Marrow Mesenchymal Stem Cell Exosome Attenuates Inflammasome-Related Pyroptosis via Delivering circ_003564 to Improve the Recovery of Spinal Cord Injury. Mol Neurobiol 2022. [PMID: 36038697 DOI: 10.1007/s12035-022-03006-y] [Reference Citation Analysis]
|
| 9 |
Soares MBP, Gonçalves RGJ, Vasques JF, da Silva-junior AJ, Gubert F, Santos GC, de Santana TA, Almeida Sampaio GL, Silva DN, Dominici M, Mendez-otero R. Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases. Front Mol Neurosci 2022;15:883378. [DOI: 10.3389/fnmol.2022.883378] [Reference Citation Analysis]
|
| 10 |
Yang ZL, Rao J, Lin FB, Liang ZY, Xu XJ, Lin YK, Chen XY, Wang CH, Chen CM. The Role of Exosomes and Exosomal Noncoding RNAs From Different Cell Sources in Spinal Cord Injury. Front Cell Neurosci 2022;16:882306. [PMID: 35518647 DOI: 10.3389/fncel.2022.882306] [Reference Citation Analysis]
|
| 11 |
Ban D, Yu P, Xiang Z, Liu Y. TNF-like weak inducer of apoptosis / nuclear factor κB axis feedback loop promotes spinal cord injury by inducing astrocyte activation. Bioengineered 2022;13:11503-16. [PMID: 35506163 DOI: 10.1080/21655979.2022.2068737] [Reference Citation Analysis]
|
| 12 |
Shan P, Wang X, Zhang Y, Teng Z, Zhang Y, Jin Q, Liu J, Ma J, Nie X. P75 neurotrophin receptor positively regulates the odontogenic/osteogenic differentiation of ectomesenchymal stem cells via nuclear factor kappa-B signaling pathway. Bioengineered 2022;13:11201-13. [PMID: 35485233 DOI: 10.1080/21655979.2022.2063495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Lv B, Shen N, Cheng Z, Chen Y, Ding H, Yuan J, Zhao K, Zhang Y. Strategies for Biomaterial-Based Spinal Cord Injury Repair via the TLR4-NF-κB Signaling Pathway. Front Bioeng Biotechnol 2022;9:813169. [DOI: 10.3389/fbioe.2021.813169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Pang QM, Chen SY, Xu QJ, Zhang M, Liang DF, Fu SP, Yu J, Liu ZL, Zhang Q, Zhang T. Effects of astrocytes and microglia on neuroinflammation after spinal cord injury and related immunomodulatory strategies. Int Immunopharmacol 2022;108:108754. [PMID: 35397392 DOI: 10.1016/j.intimp.2022.108754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Fan J, Pan J, Zhang X, Chen Y, Zeng Y, Huang L, Ma D, Chen Z, Wu G, Fan W. A peptide derived from the N-terminus of charged multivesicular body protein 6 (CHMP6) promotes the secretion of gene editing proteins via small extracellular vesicle production. Bioengineered 2022;13:4702-16. [PMID: 35188876 DOI: 10.1080/21655979.2022.2030571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Sun C, Shi C, Duan X, Zhang Y, Wang B. Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4. Bioengineered 2022;13:5915-27. [PMID: 35199612 DOI: 10.1080/21655979.2021.2023799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Dai Z, Wei G. Inhibition of miRNA-100 facilitates bone regeneration defects of mesenchymal stem cells in osteoporotic mice through the protein kinase B pathway. Bioengineered 2022;13:963-73. [PMID: 35132915 DOI: 10.1080/21655979.2021.2015880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
